Sunday 18 October 2026
Export NUVOQ’s income statement to Excel — free account
Holdco Nuvo Group D.G Ltd.
NUVOQ Healthcare Medical Devices
Holdco Nuvo Group D.G Ltd.’s revenue for fiscal 2023 (year ended December 2023) was $176,000.00.
0.00
0.00
NaN
Follow NUVOQ
| Dec '23 | Sep '23 | Jun '23 | Mar '23 | Older periods | |
|---|---|---|---|---|---|
| 63.38% | 177.90% | 169.30% | 181.36% |
+6 more TTM periods Free account |
|
| (930.47%) | (16.65%) | (12.66%) | (6.81%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
117.56% | 474.14% | 604.27% | 1,727.64% | |
Average Days of Receivables |
0.00 | — | — | — | |
Free Cash Flow per Share |
(0.83) | 0.00 | (3.58) | (1.60) | |
Free Cash Flow |
(14.96) | (14.81) | (13.94) | (13.52) | |
| Other line items | |||||
Cash ROIC |
27.02% | 82.85% | 108.19% | 125.84% | |
Average Days of Payables |
0.00 | — | — | — | |
Days of Inventory on Hand |
0.00 | — | — | — | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
— | — | (3.13) | (3.48) | |
Operating CF/Net income |
0.44 | 0.60 | 0.74 | 0.75 | |
Depreciation/Fixed assets |
0.00 | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(0.83) | 0.00 | (3.58) | (1.60) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates